MAREK, Martin, E. RAMOS-MORALES, G.F.A. PICCHI-CONSTANTE, T. BAYER, C. NORSTROM, D. HERP, P.A. SALES, E.P. GUERRA-SLOMPO, K. HAUSMANN, A. CHAKRABARTI, T.B. SHAIK, A. MERZ, E. TROESCH, K. SCHMIDTKUNZ, S. GOLDENBERG, R.J. PIERCE, MM MOURAO, M.M. JUNG, J. SCHULTZ, W. SIPPL, N.I.T. ZANCHIN and C. ROMIER. Species-selective targeting of pathogens revealed by the atypical structure and active site of Trypanosoma cruzi histone deacetylase DAC2. Cell Reports. CAMBRIDGE: Cell Press, 2021, vol. 37, No 12, p. 1-17, "e1-e9", 26 pp. ISSN 2211-1247. Available from: https://dx.doi.org/10.1016/j.celrep.2021.110129.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Species-selective targeting of pathogens revealed by the atypical structure and active site of Trypanosoma cruzi histone deacetylase DAC2
Authors MAREK, Martin (203 Czech Republic, guarantor, belonging to the institution), E. RAMOS-MORALES, G.F.A. PICCHI-CONSTANTE, T. BAYER, C. NORSTROM, D. HERP, P.A. SALES, E.P. GUERRA-SLOMPO, K. HAUSMANN, A. CHAKRABARTI, T.B. SHAIK, A. MERZ, E. TROESCH, K. SCHMIDTKUNZ, S. GOLDENBERG, R.J. PIERCE, MM MOURAO, M.M. JUNG, J. SCHULTZ, W. SIPPL, N.I.T. ZANCHIN and C. ROMIER.
Edition Cell Reports, CAMBRIDGE, Cell Press, 2021, 2211-1247.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10601 Cell biology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 9.995
RIV identification code RIV/00216224:14310/21:00124414
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1016/j.celrep.2021.110129
UT WoS 000734443900007
Keywords in English LYSINE ACETYLATION; HDAC INHIBITORS; IN-VITRO; PARASITES; POTENT; EPIGENETICS; EXPRESSION; MECHANISM; INSIGHTS; FEATURES
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 16/5/2022 12:46.
Abstract
Writing and erasing of posttranslational modifications are crucial to phenotypic plasticity and antigenic variation of eukaryotic pathogens. Targeting pathogens' modification machineries, thus, represents a valid approach to fighting parasitic diseases. However, identification of parasitic targets and the development of selective anti-parasitic drugs still represent major bottlenecks. Here, we show that the zinc-dependent his tone deacetylases (HDACs) of the protozoan parasite Trypanosoma cruzi are key regulators that have significantly diverged from their human counterparts. Depletion of T. cruzi class I HDACs tcDAC1 and tcDAC2 compromises cell-cycle progression and division, leading to cell death. Notably, tcDAC2 displays a deacetylase activity essential to the parasite and shows major structural differences with human HDACs. Specifically, tcDAC2 harbors a modular active site with a unique subpocket targeted by inhibitors showing substantial anti-parasitic effects in cellulo and in vivo. Thus, the targeting of the many atypical HDACs in pathogens can enable anti-parasitic selective chemical impairment.
PrintDisplayed: 14/7/2024 10:31